|
|
Bionomics Limited - Comparative Business Analysis Snapshot
Business Description
Bionomics Limited. The Company's principal activity is undertaking research and development utilising the Company's proprietary technology platforms with the aim of identifying and developing therapies to treat cancer and conditions of the Central Nervous System (CNS), including anxiety multiple sclerosis and epilepsy. Other activities include commercialising intellectual property assets and identifying strategic alliances and project opportunities capable of increasing shareholder value and of enhancing the its competitive advantage within the biotechnology industry. The Company operates in two geographical areas, namely Australia and France.
Competitor Analysis
This analysis compares Bionomics Limited with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
|
|
|
|
